Regenerex Pharma (RGPX) Intangibles (2011 - 2025)

Regenerex Pharma (RGPX) has 13 years of Intangibles data on file, last reported at $4340.0 in Q2 2025.

• Intangibles for Q2 2025 came in at $4340.0, up 606.84% year-over-year; the trailing twelve-month figure through Jun 2025 was $4340.0 (up 606.84% YoY), and the FY2025 annual result was $5599.0, up 321.61% from the prior year.
• Intangibles declined to $4340.0 in Q2 2025 per RGPX's latest filing, from $5599.0 in the prior quarter.
• Over five years, Intangibles peaked at $8626.0 in Q4 2021 and troughed at $208.0 in Q3 2024.
• A 5-year average of $4023.1 and a median of $4203.0 in 2023 frame the typical range for Intangibles.
• The sharpest annual moves came in 2024 and 2025: Intangibles slumped 92.48% in 2024, then soared 606.84% in 2025.
• A 5-year view of Intangibles shows it stood at $8626.0 in 2021, then sank by 43.08% to $4910.0 in 2022, then sank by 58.39% to $2043.0 in 2023, then slumped by 89.82% to $208.0 in 2024, then jumped by 1986.54% to $4340.0 in 2025.
• Business Quant data shows RGPX's Intangibles at $4340.0 in Q2 2025, $5599.0 in Q1 2025, and $208.0 in Q3 2024.